Health ❯Healthcare ❯Patient Care

Treatment Options

Combination Therapy Innovative Therapies Oral Medications Personalized Medicine Genetic Testing Intravenous Therapy Cognitive Impairment Medication Management Rare Diseases Chronic Itch Relief

Everolimus Plus Carboplatin Delays Progression in Advanced Triple-Negative Breast Cancer, Phase 2 Study Shows

Investigators call for phase 3 trials to confirm the benefit before changing care.

MHRA Licenses Teplizumab to Delay Onset of Type 1 Diabetes

Two-Dose Dalbavancin Regimen Noninferior to Standard Therapy for Complicated Staph Bacteremia

TAR-200 Clears Tumors in 82% of High-Risk Bladder Cancer Patients, Advances to FDA Priority Review

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant Lung Cancer

FDA Approves VIZZ, First Aceclidine Eye Drop for Age-Related Presbyopia

West Nile Virus Death Prompts Task Force as Cases Rise Around Rome

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

FDA Clears AI Model to Screen for Cardiac Amyloidosis

Ambroxol Demonstrates Safety and Neuroprotection Signals in Parkinson’s Dementia Trial

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Zimislecel Therapy Enters Phase 3 After Majority of Type 1 Diabetes Patients Go Insulin-Free

NHS England First Worldwide to Roll Out 'Trojan Horse' Myeloma Therapy

ASCO Conference Showcases Lifestyle-Adapted Immunotherapy and Promising Cancer Vaccines

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

Arvinas’ Vepdegestrant Delays Breast Cancer Progression Longer Than Faslodex

Biannual Zilebesiran Injections Significantly Lower Blood Pressure in Resistant Hypertension

Proteomic Test Cuts Childhood Rare Disease Diagnosis to Under Three Days

Australia Approves Donanemab as First Disease-Modifying Alzheimer’s Therapy